ORG Wealth Partners
VKTX icon

ORG Wealth Partners’s Viking Therapeutics VKTX Stock Holding History

ORG Wealth Partners’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163 Buy
+5
New +$173 ﹤0.01% 2384

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

ORG Wealth Partners's VKTX Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 5 shares worth $163. The stake represents ﹤0.01% of the portfolio and ranks #2384 among its holdings.

322 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • ORG Wealth Partners held 5 shares of Viking Therapeutics worth $163 as of Q3 2026.
  • Viking Therapeutics was a new ORG Wealth Partners position in Q3 2026.
  • Viking Therapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2384 holding.
  • 322 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.